These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 22744807

  • 21. Bone Scan Index Is an Independent Predictor of Time to Castration-resistant Prostate Cancer in Newly Diagnosed Prostate Cancer: A Prospective Study.
    Zacho HD, Gade M, Mortensen JC, Bertelsen H, Boldsen SK, Barsi T, Petersen LJ.
    Urology; 2017 Oct; 108():135-141. PubMed ID: 28760556
    [Abstract] [Full Text] [Related]

  • 22. Diagnostic performance of bone scintigraphy analyzed by three artificial neural network systems.
    Kikushima S, Hanawa N, Kotake F.
    Ann Nucl Med; 2015 Feb; 29(2):125-31. PubMed ID: 25348548
    [Abstract] [Full Text] [Related]

  • 23. A Preanalytic Validation Study of Automated Bone Scan Index: Effect on Accuracy and Reproducibility Due to the Procedural Variabilities in Bone Scan Image Acquisition.
    Anand A, Morris MJ, Kaboteh R, Reza M, Trägårdh E, Matsunaga N, Edenbrandt L, Bjartell A, Larson SM, Minarik D.
    J Nucl Med; 2016 Dec; 57(12):1865-1871. PubMed ID: 27445289
    [Abstract] [Full Text] [Related]

  • 24. Prediction of survival benefit using an automated bone scan index in patients with castration-resistant prostate cancer.
    Mitsui Y, Shiina H, Yamamoto Y, Haramoto M, Arichi N, Yasumoto H, Kitagaki H, Igawa M.
    BJU Int; 2012 Dec; 110(11 Pt B):E628-34. PubMed ID: 22788759
    [Abstract] [Full Text] [Related]

  • 25. Evaluation of bone metastatic burden by bone SPECT/CT in metastatic prostate cancer patients: defining threshold value for total bone uptake and assessment in radium-223 treated patients.
    Umeda T, Koizumi M, Fukai S, Miyaji N, Motegi K, Nakazawa S, Takiguchi T.
    Ann Nucl Med; 2018 Feb; 32(2):105-113. PubMed ID: 29243019
    [Abstract] [Full Text] [Related]

  • 26. Expert System for Bone Scan Interpretation Improves Progression Assessment in Bone Metastatic Prostate Cancer.
    Haupt F, Berding G, Namazian A, Wilke F, Böker A, Merseburger A, Geworski L, Kuczyk MA, Bengel FM, Peters I.
    Adv Ther; 2017 Apr; 34(4):986-994. PubMed ID: 28265811
    [Abstract] [Full Text] [Related]

  • 27. Prospective evaluation of computer-assisted analysis of skeletal lesions for the staging of prostate cancer.
    Petersen LJ, Mortensen JC, Bertelsen H, Zacho HD.
    BMC Med Imaging; 2017 Jul 10; 17(1):40. PubMed ID: 28693433
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Comparison of diagnostic precision for bone metastasis of primary breast cancer between BONENAVI version 1 and BONENAVI version 2.
    Okada Y, Matsushita S, Nakajima Y, Yamaguchi K, Okuda I, Kojima Y, Tsugawa K.
    Nucl Med Commun; 2019 Nov 10; 40(11):1148-1153. PubMed ID: 31469804
    [Abstract] [Full Text] [Related]

  • 31. Scoring systems of quantitative bone scanning in prostate cancer: historical overview, current status and future perspectives.
    Zafeirakis A.
    Hell J Nucl Med; 2014 Nov 10; 17(2):136-44. PubMed ID: 24997079
    [Abstract] [Full Text] [Related]

  • 32. Evaluation of a computer-assisted diagnosis system, BONENAVI version 2, for bone scintigraphy in cancer patients in a routine clinical setting.
    Koizumi M, Wagatsuma K, Miyaji N, Murata T, Miwa K, Takiguchi T, Makino T, Koyama M.
    Ann Nucl Med; 2015 Feb 10; 29(2):138-48. PubMed ID: 25326907
    [Abstract] [Full Text] [Related]

  • 33. [Bone scintigraphy in prostatic cancer. Correlation with clinical and laboratory features and with survival].
    Lobo G, Ladrón de Guevara D, Salgado G, Donoso G, Bagus F.
    Rev Med Chil; 1999 Feb 10; 127(2):181-8. PubMed ID: 10436698
    [Abstract] [Full Text] [Related]

  • 34. Should bone scan be performed in Chinese prostate cancer patients at the time of diagnosis?
    Wang Y, Guo J, Xu L, Zhao N, Xu Z, Wang H, Zhu Y, Jiang S, Yang N, Yang Y, Wang G.
    Urol Int; 2013 Feb 10; 91(2):160-4. PubMed ID: 23548369
    [Abstract] [Full Text] [Related]

  • 35. Prognostic significance of extent of disease in bone in patients with androgen-independent prostate cancer.
    Sabbatini P, Larson SM, Kremer A, Zhang ZF, Sun M, Yeung H, Imbriaco M, Horak I, Conolly M, Ding C, Ouyang P, Kelly WK, Scher HI.
    J Clin Oncol; 1999 Mar 10; 17(3):948-57. PubMed ID: 10071289
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. A new parameter for measuring metastatic bone involvement by prostate cancer: the Bone Scan Index.
    Imbriaco M, Larson SM, Yeung HW, Mawlawi OR, Erdi Y, Venkatraman ES, Scher HI.
    Clin Cancer Res; 1998 Jul 10; 4(7):1765-72. PubMed ID: 9676853
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Evaluation of two-dimensional total bone uptake (2D-TBU) and bone scan index (BSI) extracted from active bone metastatic burden on the bone scintigraphy in patients with radium-223 treatment.
    Fukai S, Daisaki H, Umeda T, Shimada N, Terauchi T, Koizumi M.
    Ann Nucl Med; 2024 Jun 10; 38(6):450-459. PubMed ID: 38517659
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.